AU778834B2 - Fatty acid analogs for diagnosis of coronary artery disease - Google Patents

Fatty acid analogs for diagnosis of coronary artery disease Download PDF

Info

Publication number
AU778834B2
AU778834B2 AU42433/00A AU4243300A AU778834B2 AU 778834 B2 AU778834 B2 AU 778834B2 AU 42433/00 A AU42433/00 A AU 42433/00A AU 4243300 A AU4243300 A AU 4243300A AU 778834 B2 AU778834 B2 AU 778834B2
Authority
AU
Australia
Prior art keywords
fatty acid
radiolabeled fatty
radioisotope
radiolabeled
sum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42433/00A
Other languages
English (en)
Other versions
AU4243300A (en
Inventor
John W Babich
David R. Elmaleh
Kevin Maresca
Timothy Shoup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Insight Pharmaceuticals Inc
Original Assignee
Biostream Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostream Inc filed Critical Biostream Inc
Publication of AU4243300A publication Critical patent/AU4243300A/en
Application granted granted Critical
Publication of AU778834B2 publication Critical patent/AU778834B2/en
Assigned to MOLECULAR INSIGHT PHARMACEUTICALS, INC. reassignment MOLECULAR INSIGHT PHARMACEUTICALS, INC. Request to Amend Deed and Register Assignors: BIOSTREAM, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fats And Perfumes (AREA)
AU42433/00A 1999-04-14 2000-04-14 Fatty acid analogs for diagnosis of coronary artery disease Ceased AU778834B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12929899P 1999-04-14 1999-04-14
US60/129298 1999-04-14
PCT/US2000/010096 WO2000061196A2 (en) 1999-04-14 2000-04-14 Fatty acid analogs for diagnosis of coronary artery disease

Publications (2)

Publication Number Publication Date
AU4243300A AU4243300A (en) 2000-11-14
AU778834B2 true AU778834B2 (en) 2004-12-23

Family

ID=22439338

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42433/00A Ceased AU778834B2 (en) 1999-04-14 2000-04-14 Fatty acid analogs for diagnosis of coronary artery disease

Country Status (9)

Country Link
US (1) US6437103B1 (cg-RX-API-DMAC7.html)
EP (1) EP1173226B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003517457A (cg-RX-API-DMAC7.html)
AT (1) ATE337020T1 (cg-RX-API-DMAC7.html)
AU (1) AU778834B2 (cg-RX-API-DMAC7.html)
CA (1) CA2366789C (cg-RX-API-DMAC7.html)
DE (1) DE60030270T2 (cg-RX-API-DMAC7.html)
ES (1) ES2269131T3 (cg-RX-API-DMAC7.html)
WO (1) WO2000061196A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2374743T3 (es) * 1995-12-01 2012-02-21 Molecular Insight Pharmaceuticals, Inc. Estereoisómeros de análogos de ácidos grasos para imagen de diagnóstico.
US7381399B2 (en) * 2002-03-11 2008-06-03 Molecular Insight Pharmaceuticals, Inc. Technetium-dipyridine complexes, and methods of use thereof
AU2003226169C1 (en) * 2002-04-01 2010-01-07 Molecular Insight Pharmaceuticals, Inc. Pendant fatty acid imaging agents
EP1622602B1 (en) * 2003-04-17 2008-08-20 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
KR100533674B1 (ko) * 2004-02-25 2005-12-06 한국원자력연구소 수소화붕소 교환수지를 이용한 레늄 착물의 제조방법
US20080226555A1 (en) * 2005-06-08 2008-09-18 Bengt Langstrom Method for the Use of [11C] Carbon Monoxide in Labeling Synthesis of 11C-Labelled Esters and Acids by Sensitized Photo-Induced Free Radical

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524059A (en) * 1983-01-28 1985-06-18 The General Hospital Corporation Fatty acid analogs
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4746505A (en) * 1985-04-26 1988-05-24 President And Fellows Of Harvard College Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands
ES2374743T3 (es) * 1995-12-01 2012-02-21 Molecular Insight Pharmaceuticals, Inc. Estereoisómeros de análogos de ácidos grasos para imagen de diagnóstico.

Also Published As

Publication number Publication date
DE60030270D1 (de) 2006-10-05
ATE337020T1 (de) 2006-09-15
JP2003517457A (ja) 2003-05-27
AU4243300A (en) 2000-11-14
CA2366789A1 (en) 2000-10-19
US6437103B1 (en) 2002-08-20
WO2000061196A2 (en) 2000-10-19
EP1173226A2 (en) 2002-01-23
ES2269131T3 (es) 2007-04-01
CA2366789C (en) 2010-09-28
WO2000061196A3 (en) 2001-07-26
DE60030270T2 (de) 2007-08-30
EP1173226B1 (en) 2006-08-23

Similar Documents

Publication Publication Date Title
US4925650A (en) Technetium -99m complex for examining the renal function
AU2020262961B2 (en) Prostate-specific membrane antigen (PSMA) inhibitors as diagnostic and radionuclide therapeutic agents
Volkert et al. Technetium-99m chelates as radiopharmaceuticals
Kung New technetium 99m-labeled brain perfusion imaging agents
Oya et al. Small and neutral TcvO BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents
US5986074A (en) Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof
AU2004210208B2 (en) Diagnostic imaging agents with MMP inhibitory activity
Choi et al. An improved kit formulation of a dopamine transporter imaging agent:[Tc-99m] TRODAT-1
NZ263794A (en) Compound suitable for forming tc and re chelates, radiopharmaceutical compositions thereof
JPH06502640A (ja) テクネチウム−99m錯化合物の放射性医薬としての使用
EP1173226B1 (en) Fatty acid analogs for diagnosis of coronary artery disease
JP4338394B2 (ja) テクネチウム−99m窒化物ヘテロ錯体を含有する放射性画像診断剤
US5876693A (en) Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals
JPH06501450A (ja) シクロペンタジエニルカルボニル―99mTc錯体、その製造法および診断学への該化合物の使用
EP0949265B1 (en) Radioactive transition metal nitride hetero-complex
Jones Jr et al. Synthesis and biodistribution of a new 99mtechnetium fatty acid
Ohmomo et al. New conformationally restricted technetium-99m N2S2 complexes as myocardial perfusion imaging agents
Kothari et al. Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP2) chelate
Cazzola et al. Labeling of fatty acid ligands with the strong electrophilic metal fragment [99mTc (N)(PNP)] 2+(PNP= diphosphane ligand)
Zhuang et al. Neutral and stereospecific Tc-99m complexes:[99mTc] N-benzyl-3, 4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT)
Blau Radiotracers for functional brain imaging
WO2023100852A1 (ja) 安定化放射性医薬組成物
Eckelman et al. Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution
JP2564459B2 (ja) 放射性医薬品調製用キャリヤー
US20040087567A1 (en) Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition